Key result
ABCA1 deficiency eliminates nascent HDL formation and accelerates triglyceride secretion in human hepatocytes.
Why the study?
The functional effects of ABCA1 deficiency in human hepatocytes and its impact on HDL metabolism and triglyceride secretion are not well understood.
Hepatic ABCA1 deficiency abrogates HDL biogenesis and increases triglyceride and ANGPTL3 secretion, providing a potential mechanism for elevated plasma TG in Tangier disease.
iPSC-HLC models show ABCA1 loss abolishes nascent HDL yet raises TG secretion; leaves open ANGPTL3's role in Tangier hypertriglyceridemia.
Despite the recognized role of the ATP-binding Cassette Transporter A1 (ABCA1) in high-density lipoprotein (HDL) metabolism, our understanding of ABCA1 deficiency in human hepatocytes is limited. To define the functional effects of human hepatocyte ABCA1 deficiency, we generated induced pluripotent stem cell (iPSC)-derived hepatocyte-like cells (HLCs) from Tangier disease (TD) and matched control subjects. Control HLCs exhibited robust cholesterol efflux to apolipoprotein A-I (apoA-I) and formed nascent HDL particles. ABCA1-deficient HLCs failed to mediate lipid efflux or nascent HDL formation, but had elevated triglyceride (TG) secretion. Global transcriptome analysis revealed significantly increased ANGPTL3 expression in ABCA1-deficient HLCs. Angiopoietin-related protein 3 (ANGPTL3) was enriched in plasma of TD relative to control subjects. These results highlight the required role of ABCA1 in cholesterol efflux and nascent HDL formation by hepatocytes. Furthermore, our results suggest that hepatic ABCA1 deficiency results in increased hepatic TG and ANGPTL3 secretion, potentially underlying the elevated plasma TG levels in TD patients.
No takes yet. Share an insight, caveat, or question.
Bi et al. (2017) studied Tangier disease (ABCA1 deficiency). ABCA1 deficiency vs. Matched control subjects was evaluated on Cholesterol efflux, nascent HDL formation, and triglyceride secretion. ABCA1 deficiency in human iPSC-derived hepatocytes abrogated lipid efflux and nascent HDL formation while increasing triglyceride secretion and ANGPTL3 expression compared to controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: